Cargando…

DNA vaccines expressing conserved elements provide potent and broad immune responses

Detalles Bibliográficos
Autores principales:	Pavlakis, GN, Kulkarni, V, Valentin, A, Rosati, M, Sardesai, NY, Mothe, B, Brander, C, LeGall, S, Weiner, DB, Rolland, M, Mullins, JI, Felber, BK
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441506/ http://dx.doi.org/10.1186/1742-4690-9-S2-O67

Ejemplares similares

A minimal T-cell immunogen designed to cover HIV-1 specificities associated with control is immunogenic in mice and breaks CTL immunodominance
por: Mothe, B, et al.
Publicado: (2012)

Altered Response Hierarchy and Increased T-Cell Breadth upon HIV-1 Conserved Element DNA Vaccination in Macaques
por: Kulkarni, Viraj, et al.
Publicado: (2014)

HIV-1 Conserved Elements p24CE DNA Vaccine Induces Humoral Immune Responses with Broad Epitope Recognition in Macaques
por: Kulkarni, Viraj, et al.
Publicado: (2014)

HIV-1 p24(gag) Derived Conserved Element DNA Vaccine Increases the Breadth of Immune Response in Mice
por: Kulkarni, Viraj, et al.
Publicado: (2013)

OA06-02. Monospecific expansion of SIVmac251 during acute infection masks multiple transmitted virus variants revealed during the chronic phase
por: Felber, BK, et al.
Publicado: (2009)

Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques
por: Hu, Xintao, et al.
Publicado: (2018)

HIV Env conserved element DNA vaccine alters immunodominance in macaques
por: Hu, Xintao, et al.
Publicado: (2017)

A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques
por: Mothe, Beatriz, et al.
Publicado: (2015)

OAO5-04. Gp96-Ig-SIV vaccines induce predominant immune responses at mucosal sites
por: Strbo, N, et al.
Publicado: (2009)

OA05-02. Analysis of DNA compared to Ad5 vaccination, as single and mixed modalities, demonstrates robust induction of cellular immune responses in macaques
por: Hirao, LA, et al.
Publicado: (2009)

Co-immunization with HIV Env DNA and protein elicit long-lasting strong cellular and humoral immune responses
por: Li, J, et al.
Publicado: (2012)

Minimally invasive and surface electroporation delivery of DNA vaccines for the induction of robust humoral immune responses against HIV antigens
por: Sardesai, NY, et al.
Publicado: (2012)

DNA Vaccine–Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination
por: Hu, Xintao, et al.
Publicado: (2018)

CTL Responses of High Functional Avidity and Broad Variant Cross-Reactivity Are Associated with HIV Control
por: Mothe, Beatriz, et al.
Publicado: (2012)

P18-09. Persistent virological benefit in SIV-infected macaques upon therapeutic vaccination upon vaccination with DNA vectors
por: Felber, BK, et al.
Publicado: (2009)

Preservation of a subset of SIV-specific central memory CD4+ T cells correlates with control of viremia in SIVmac251 infected macaques
por: Felber, Barbara K, et al.
Publicado: (2006)

Comparison of cellular and humoral immune responses induced by primary, consensus or mosaic HIV-1 Env DNA vaccines
por: Yan, J, et al.
Publicado: (2012)

Preferential depletion of a splenic marginal zone-like peripheral blood CD27+B220- memory B cell population in HIV-1 infected individuals
por: Morrow, M, et al.
Publicado: (2006)

Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial
por: Tebas, P, et al.
Publicado: (2012)

P14-08. Intramuscular DNA delivery by electroporation leads to greatly enhanced systemic and mucosal immune responses and control of SIVmac251 challenge
por: Pavlakis, GN, et al.
Publicado: (2009)

P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
por: Valentin, A, et al.
Publicado: (2009)

Intramuscular delivery of heterodimeric IL-15 DNA in macaques produces systemic levels of bioactive cytokine inducing proliferation of NK and T cells
por: Bergamaschi, C, et al.
Publicado: (2015)

P12-09. Immune responses in controlled and uncontrolled HIV infection to a designed HIV immunogen sequence focused on conserved regions of the viral genome
por: Mothe, B, et al.
Publicado: (2009)

Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques
por: Valentin, Antonio, et al.
Publicado: (2022)

Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques
por: Valentin, Antonio, et al.
Publicado: (2015)

Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection
por: Munson, Paul, et al.
Publicado: (2018)

454 pyrosequencing and bioinformatics analysis of the lineage of the broad and potent gp41-directed antibody 10e8
por: Ofek, G, et al.
Publicado: (2012)

HIV DNA Vaccine: Stepwise Improvements Make a Difference
por: Felber, Barbara K., et al.
Publicado: (2014)

A synthetic consensus anti-Spike protein DNA vaccine induces protective immunity against Middle East Respiratory Syndrome Coronavirus in non-human primates
por: Muthumani, K., et al.
Publicado: (2016)

HIV-1 Group M Conserved Elements Vaccine
por: Rolland, Morgane, et al.
Publicado: (2007)

Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates
por: Dross, Sandra, et al.
Publicado: (2023)

Broad and Gag-Biased HIV-1 Epitope Repertoires Are Associated with Lower Viral Loads
por: Rolland, Morgane, et al.
Publicado: (2008)

S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target
por: Phogat, SK, et al.
Publicado: (2009)

134. KRP-A218, an Orally Active and Selective PI4KB Inhibitor with Broad-Spectrum Anti-Rhinovirus Activity, Has Potent Therapeutic Antiviral Activity In vivo
por: Matsui, Toshiyuki, et al.
Publicado: (2021)

Engineered mice and B cell lines expressing broadly neutralizing antibodies and their unmutated precursors: tools for HIV vaccinology
por: Nemazee, D, et al.
Publicado: (2012)

The p40 Subunit of Interleukin (IL)-12 Promotes Stabilization and Export of the p35 Subunit: IMPLICATIONS FOR IMPROVED IL-12 CYTOKINE PRODUCTION
por: Jalah, Rashmi, et al.
Publicado: (2013)

Novel strategy for generation of mucosal immune responses against HIV-1 following systemic vaccination
por: Kutzler, Michele A, et al.
Publicado: (2006)

S011-06 OA. HIV specific T cell responses and response patterns associated with viral control independent of classical non-progessor HLA class I alleles
por: Zuniga, R, et al.
Publicado: (2009)

In the era of broad spectrum antibiotics, is ampicillin still an option?
por: Popescu, Cristina, et al.
Publicado: (2013)

Small steps forward for HIV vaccine development
por: Mothe, Beatriz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8d6s547h33805gh8hspv87usv5